Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR known ✓ | P04035 | 6/20 | 0.62 |
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.62 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.62 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.62 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.62 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.62 |
| ▸ | PGR | P06401 | 1/20 | 0.62 |
| ▸ | RXRA | P19793 | 1/20 | 0.62 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.62 |
| ▸ | CCKAR | P32238 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31517659 | 1.00 | CYP2C9 (0.75) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| SCHEMBL31517681 | 1.00 | CYP2C9 (0.75) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| SCHEMBL31517768 | 0.93 | CYP2C9 (0.77) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| SCHEMBL31517729 | 0.93 | CYP2C9 (0.77) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| SCHEMBL6270540 | 0.90 | HMGCR (0.74) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| SCHEMBL31517686 | 0.86 | CYP2C9 (0.59) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| Fluvastatin SCHEMBL6251405 | 0.85 | CYP2C9 (1.00) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| Fluvastatin SCHEMBL41503 | 0.85 | CYP2C9 (1.00) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| Fluvastatin SCHEMBL41663 | 0.85 | CYP2C9 (1.00) | CYP2C9KDM4EALDH1A1LMNACYP1A2 | |
| Fluvastatin SCHEMBL41502 | 0.85 | CYP2C9 (1.00) | CYP2C9KDM4EALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4929437-A | Coenzyme Q10 with HMG-CoA reductase inhibitors | MERCK & CO., INC. (US) | 1990-05-29 | — | — | US | claimed |
| US-9168141-B2 | Medical prosthetic devices and implants having improved biocompatibility | ASTRA TECH AB (SE) | 2015-10-27 | — | — | US | disclosed |
| US-20120130491-A1 | MEDICAL PROSTHETIC DEVICES HAVING IMPROVED BIOCOMPATIBILITY | STRAUMANN HOLDING AG (CH) | 2012-05-24 | — | — | US | disclosed |
| US-20110124819-A1 | MODIFIED HALOGENATED POLYMER SURFACES | BASF SE (DE) | 2011-05-26 | — | — | US | disclosed |
| US-20080269910-A1 | Medical prosthetic devices having improved biocompatibility | STRAUMANN HOLDING AG (CH) | 2008-10-30 | — | — | US | disclosed |
| EP-1492579-B1 | MEDICAL PROSTHETIC DEVICES HAVING IMPROVED BIOCOMPATIBILITY | NUMAT AS (NO) | 2008-09-10 | — | — | EP | disclosed |
| US-7410502-B2 | Medical prosthetic devices having improved biocompatibility | NUMAT AS (NO) | 2008-08-12 | — | — | US | disclosed |
| US-20070077346-A1 | MEDICAL PROSTHETIC DEVICES AND IMPLANTS HAVING IMPROVED BIOCOMPATIBILITY | STRAUMANN HOLDING AG (CH) | 2007-04-05 | — | — | US | disclosed |
| US-7192445-B2 | Medical prosthetic devices and implants having improved biocompatibility | ASTRA TECH AB (SE) | 2007-03-20 | — | — | US | disclosed |
| US-20060155384-A1 | Medical prosthetic devices and implants having improved biocompatibility | NUMAT AS (NO) | 2006-07-13 | — | — | US | disclosed |
| EP-1492579-A1 | MEDICAL PROSTHETIC DEVICES HAVING IMPROVED BIOCOMPATIBILITY | Astra Tech AB (SE) | 2005-01-05 | — | — | EP | disclosed |
| EP-1339437-B1 | MEDICAL PROSTHETIC DEVICES AND IMPLANTS COATED WITH METAL HYDRIDES AND BIOMOLECULES HAVING IMPROVED BIOCOMPATIBILITY | ASTRA TECH AB (SE) | 2004-07-28 | — | — | EP | disclosed |
| US-20040083006-A1 | Medical prosthetic devices having improved biocompatibility | ASTRA TECH AB (NO) | 2004-04-29 | — | — | US | disclosed |
| WO-2003086495-A1 | MEDICAL PROSTHETIC DEVICES HAVING IMPROVED BIOCOMPATIBILITY | ASTRA TECH AB (SE) | 2003-10-23 | — | — | WO | disclosed |
| EP-1339437-A1 | MEDICAL PROSTHETIC DEVICES AND IMPLANTS HAVING IMPROVED BIOCOMPATIBILITY | Astra Tech AB (SE) | 2003-09-03 | — | — | EP | disclosed |
| US-20020111694-A1 | Medical prosthetic devices and implants having improved biocompatibility | BIOTI AS (NO) | 2002-08-15 | — | — | US | disclosed |
| WO-2002045764-A1 | MEDICAL PROSTHETIC DEVICES AND IMPLANTS HAVING IMPROVED BIOCOMPATIBILITY | ASTRA TECH AB (SE) | 2002-06-13 | — | — | WO | disclosed |